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ymphocyte development occurs in
a stepwise progression through distinct developmental stages. This ordered
maturation ensures that cells express a
single, non-autoreactive antigen receptor, which is the cornerstone of a diverse
adaptive immune response. Expression
of a mature antigen receptor requires
assembly of the antigen receptor genes
by the process of V(D)J recombination, a
reaction that joins distant gene segments
through DNA double-strand break
(DSB) intermediates. These physiologic
DSBs are generated by the recombinaseactivating gene (RAG) -1 and -2 proteins,
and their generation is regulated by lymphocyte and developmental stage-specific signals from cytokine receptors and
antigen receptor chains. Collectively,
these signals ensure that V(D)J recombination of specific antigen receptor
genes occurs at discrete developmental
stages. Once generated, RAG-induced
DSBs activate the ataxia-telangiectasia
mutated (ATM) kinase to orchestrate a
multifaceted DNA damage response that
ensures proper DSB repair. In response
to RAG DSBs, ATM also regulates a cell
type-specific transcriptional response,
and here we discuss how this genetic program integrates with other cellular cues
to regulate lymphocyte development.
Introduction
Lymphocytes proceed through discrete
stages as they develop into mature B and T
cells. Lymphocyte-specific, stage-specific
and lineage-specific signals direct differentiation to ensure that each cell uniquely
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expresses the appropriate antigen receptor
genes at the correct developmental stage.
These signals culminate in the assembly
of functional antigen receptor genes and
expression of a non-autoreactive antigen
receptor. The second exon of all antigen
receptor genes must be assembled from
variable (V), joining (J) and, at some loci,
diversity (D) gene segments.1 These distinct gene segments are joined through
the generation and repair of DNA breaks.
This process of V(D)J recombination is
initiated by the recombinase-activating
genes, RAG1 and RAG2, which encode
proteins that, together, form the RAG
endonuclease.2-4 RAG binds to recombination signals, specific DNA sequences,
at the border of the V, D and J segments
and generates DNA double-strand breaks
(DSBs).2-4 These RAG DSBs are processed and joined by the non-homologous
end-joining (NHEJ) pathway of DNA
DSB repair.5-7
In developing B lymphocytes, the
heavy chain (IgH) gene is rearranged first
at the pro-B cell stage and is expressed
in conjunction with the surrogate light
chains (VpreB and λ5) to form the preBCR.8 Expression of the pre-BCR signals
transition to the pre-B cell developmental
stage.8 Pre-B cells subsequently assemble a
functional light chain (IgL) gene at either
the kappa (IgLκ) or lambda (IgLλ) locus.9
The ordered rearrangement of IgH and
IgL genes is regulated by diverse cellular
signals.
In pre-B cells, the interleukin-7
receptor (IL-7r) and the pre-BCR are
the principal regulators of cell proliferation, survival and maturation.8,10,11 These
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RAG DSBs Activate Canonical
DNA Damage Responses
RAG DSBs are generated in the G1 phase
of the cell cycle as RAG2 is phosphorylated
and degraded upon entry into S-phase.12
Similar to other DSBs generated in G1,
RAG DSBs trigger canonical DNA damage responses through activation of ATM
and DNA-PKcs, which are both members of the phosphatidylinositol-3-kinase
(PI3K)-like family of serine-threonine
kinases.5-7 Both ATM and DNA-PKcs
function as transducers in the DNA damage response to phosphorylate numerous
downstream effectors.13-16
ATM and DNA-PKcs have unique
and redundant roles in response to RAGmediated DSBs.5,17,18 Deficiency of either
of these kinases results in errors in repair
of the broken DNA ends and immune
deficiencies in mice and humans.5,7,19-23
Following induction of RAG DSBs,
ATM is responsible for promoting the stability of the broken DNA (coding) ends
in a post-cleavage complex until they are
joined.24 DNA-PKcs promotes the activity of the Artemis endonuclease, which is
required to open hairpin-sealed ends generated by the RAG endonuclease.15,25,26
These kinases function in conjunction
with other NHEJ proteins to ensure
proper repair of RAG DSBs.5-7 Moreover,
ATM phosphorylates the histone variant
H2AX (γ-H2AX) for several kilobases
surrounding DNA breaks, including RAG
DSBs.27-29 Phosphorylated H2AX recruits
proteins to the site of the DNA break,
amplifying DNA damage responses and
supporting normal DSB repair, including
preventing the resection of RAG-induced
DSBs.28,30
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RAG DSBs Activate a Unique
Transcriptional Program
In addition to signals important in DSB
repair, RAG DSBs also activate programs
that regulate broader cellular responses.
Similar to genotoxic DSBs, in response
to RAG DSBs, ATM phosphorylates the
transcription factor p53, resulting in its
stabilization and increased transcriptional
activity.31-35 Once activated, p53 regulates
the expression of numerous cell cycle and
cell death genes, including p21, PUMA,
NOXA and BAX.33,36 Deficiency of p53
results in a higher incidence of lymphoid
malignancies with chromosomal translocations, consistent with an important role
for this tumor suppressor in eliminating
cells at risk for aberrant DNA repair and
malignant transformation.33,37-41 However,
mechanisms must exist to ensure that
p53 does not induce the death of all cells
attempting to assemble antigen receptor
genes.
Indeed, RAG DSBs trigger NFκBdependent transcription, which regulates expression of a genetic program that
includes survival genes.31,42 The dual regulation of survival and cell death pathways
by RAG DSBs is temporally balanced,
allowing time for proper assembly of the
antigen receptor genes, but ensuring elimination of cells with persistent DSBs at risk
for errant repair. These opposing processes
may enforce normal development and suppress malignant transformation. Moreover,
RAG DSBs initiate expression of lymphocyte-specific cellular programs that integrate with other developmental cues in
pre-B cells, including those initiated by the
IL-7r and pre-BCR, and support lymphocyte differentiation and maturation.42
IL-7r Signaling in Pre-B Cells
IL-7 signaling is critical for early lymphocyte development, as evidenced by
the block in B and T cell maturation at
early stages in mice deficient in IL-7 or
the IL-7r.10,43,44 In pre-B cells, the IL-7r
signals through both the JAK-STAT and
the PI3K-Akt pathways to support cell
survival and proliferation while simultaneously suppressing IgL gene accessibility
and RAG expression.10 In this manner,
IL-7 induces clonal expansion of pre-B
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cells and prevents generation of RAG
DSBs at antigen receptor loci in actively
dividing cells.
Activation of the IL-7r in pre-B cells
leads to phosphorylation and dimerization of STAT5, which results in nuclear
translocation and initiation of gene
expression.10,45,46 STAT5 mediates the
upregulation of anti-apoptotic and proliferation genes, including Bcl2, Bcl-X L , Mcl-1
and Pim-1, CCND2 (cyclin-D2) and
CCND3 (cyclin-D3).10,45,46 Additionally,
STAT5 coordinates increased accessibility
of the IgH locus and simultaneous inactivation of the IgL locus, thereby preventing
light chain recombination.46-48
The IL-7r also phosphorylates and activates the Akt (PKB) kinase, which cooperates with STAT5 signaling to support
pre-B cell survival at least in part through
phosphorylation and inactivation of the
pro-apoptotic protein BAD.10,31,49 Akt also
phosphorylates the FoxO1 and FoxO3a
transcription factors resulting in their
cytoplasmic retention and inactivation.50-53
Attenuation of IL-7 signals disables Akt
and stabilizes the FoxO transcription factors, resulting in expression of RAG and
activation of IgL gene rearrangement.50-53
As such, loss of IL-7 signals is necessary
for IgL chain gene assembly, but the concomitant loss of survival signals would be
detrimental to pre-B cells.
Pre-BCR Signaling
Ligand-independent oligomerization of
the pre-BCR promotes pathways that participate in the regulation of cellular proliferation, allelic exclusion of the IgH chain
gene and activation of IgLκ chain gene
rearrangement.8,54-56 The pre-BCR signals
through the Igα and Igβ subunits to activate multiple downstream pathways.8,54
Activation of the RAS kinase triggers a
kinase cascade that includes MEK to ERK
activation, which leads to expression of the
Aiolos transcriptional repressor and the
E2A transcription factor.48 Aiolos inhibits
expression of CCND3 (cyclin-D3) to support cell cycle arrest, while E2A activates
transcription of the IgLκ chain genes.48
Additionally, pre-BCR signals support
PI3K-Akt signaling, thus, augmenting
IL-7r signaling through this pathway to
suppress FoxO transcriptional activity and
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signals cooperate to regulate accessibility of the antigen receptor genes, RAG
expression and transcriptional programs
necessary for cell type-specific differentiation.8,10 In addition to these cell surface
receptors, recent studies have shown that
signals from RAG DNA breaks activate
genetic programs that have important
consequences for developing lymphocytes.
Here we review how these DSB-dependent
signals are integrated with other signals
that drive lymphocyte development and
differentiation.

©2012 Landes Bioscience. Do not distribute.

inhibit RAG expression.50,51 The pre-BCR
complex also activates SLP-65 (BLNK),
which further augments Aiolos expression and upregulates expression of IRF4,
another important regulator of IgLκ transcription.57,58 Pre-BCR signals have also
been demonstrated to promote proliferation in conditions of low IL-7 concentrations and to upregulate expression of the
chemokine receptor CXCR4, which promotes migration of pre-B cells to distinct
bone marrow compartments in response
to its ligand CXCL12.8,58
Integration of IL-7 receptor
and pre-BCR signals
The IL-7r and the pre-BCR combine
to provide signals necessary for ongoing B cell maturation. The integration of
these signaling pathways controls pre-B
cell proliferation, survival and IgL chain
gene recombination.8,10,11 IL-7r signals
promote cell proliferation while simultaneously suppressing RAG expression and
IgLκ chain gene accessibility.10,53,58 These
signals must be attenuated for continued
differentiation. Pre-BCR signaling may,
in part, regulate IL-7 signaling through
downregulation of IL-7r expression.59,60
Moreover, pre-BCR signals upregulate
CXCR4 expression, which can promote
cell migration in response to CXCL12 to
bone marrow microenvironments that are
devoid of IL-7-producing stromal cells.58
As IL-7 diminishes, PI3K-Akt signaling
ceases, resulting in activation of FoxO
transcription factors and expression of the
RAG machinery.53 Additionally, loss of
IL-7 signals triggers increased expression
of SLP-65 (BLNK) and Syk, two critical
intracellular signaling components of the
pre-BCR, which, in turn, activate Aiolos
and IRF4 expression to suppress proliferation and activate IgLκ transcription,
respectively.53,57,58 In this manner, the
IL-7r and the pre-BCR cooperate to control RAG expression, IgLκ accessibility
and B cell maturation.
Regulation of Lymphocyte
Developmental Processes by RAG
DSB Signaling
In addition to the extrinsic signals from
the IL-7r and pre-BCR, pre-B cells are also
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Figure 1. Integration of surface receptor signals and DNA damage responses in pre-B cells. In developing pre-B cells, signals from the IL-7r, pre-BCR and RAG DSBs coordinate to direct continued
maturation. In large pre-B cells, IL-7r and pre-BCR signals support proliferation and survival to
optimize clonal expansion of IgH-expressing cells. This proliferation phase occurs in bone marrow
niches rich in IL-7-producing cells. IL-7r signals through STAT5 and Akt to maintain proliferation
and survival. Additionally, STAT5 supports IgH chain gene transcription and suppresses IgL chain
gene accessibility while Akt inhibits RAG expression. Pre-BCR signals support Akt signaling during this expansion phase. Attenuation of IL-7r signaling, which may be mediated by migration of
pre-B cells to bone marrow niches devoid of IL-7-producing cells, results in transition to the small
pre-B cell developmental stage. Loss of IL-7 results in termination of STAT5 signals and associated
cell cycle arrest. The cessation of Akt activity results in stabilization of FoxO transcription factors
and expression of RAG and SLP-65. SLP-65 redirects pre-BCR signaling to expression of IRF4 and
transcription of IgL chain genes, which permits IgL locus accessibility to RAG. RAG DSBs trigger
ATM-dependent DNA damage responses (DDR), which intersect with pre-BCR signals to promote
pre-B cell survival, suppress IL-7-driven proliferation and trigger expression of proteins that support cellular re-localization.

influenced by intrinsic signals triggered
by the DSBs generated during IgL chain
gene rearrangement. Initiation of IgL
chain gene assembly requires the attenuation of IL-7 signaling, which results in
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concomitant loss of Pim1 and Akt survival
signals with rapid induction of cell death
mechanisms.10,31,53,61,62 However, shortly
after their generation during IgL chain
gene assembly, RAG DSBs upregulate

3

4

signaling and maintain cell cycle arrest.
In this regard, DNA damage responses
and antigen receptor signals cooperate
to prevent pre-B cells with RAG DSBs
from entering S-phase, where these DNA
breaks could be repaired as translocations
or as replicated broken chromosomes.
In pre-B cells RAG DSBs also induce
expression of genes with known functions
in lymphocyte migration and homing
such as CD69, L-selection (CD62L) and
SWAP-70.42,68-72 SWAP-70 and L-selectin
regulate integrin-mediated adhesion and
chemokine responses, respectively, to
control lymphocyte homing to secondary
lymphoid organs.69,70,73,74 CD69 mediates
downregulation of the S1P1 receptor,
which binds to sphingosine-1-phosphate
(S1P) and promotes egress of lymphocytes out of the thymus and other secondary lymphoid organs.71,72 The S1P1
receptor is also required to promote the
migration of newly generated B cells
from the bone marrow.75,76 Expression of
CD69 blocks S1P1 receptor expression
in immature B cells and prevents their
migration into the periphery.75 Thus, the
induction of CD69 by RAG DSBs may
prevent pre-B cells from exiting the bone
marrow prior to completing IgL chain
gene assembly. Moreover, expression of
CD69, SWAP-70 and L-selectin by RAG
DSBs may function in conjunction with
signals from the pre-BCR, which promote CXCR4 expression and migration
away from IL-7-producing stromal cells.58
In this regard, the combination of antigen receptor and DSB-dependent signals
could promote the residence of pre-B cells
in bone marrow compartments devoid
of IL-7 while they complete assembly of
the IgL chain genes and expression of a
mature BCR.
Interestingly, regulation of developmental programs by physiologic DSBs
is also observed during later stages of
B cell development in the spleen. The
DNA DSBs generated during class switch
recombination in mature B cells promote
a transcriptional program that controls
differentiation of activated B cells into
plasma cells.77,78 Thus, signals from physiologic DSBs regulate cell type-specific
genetic programs that function at various
stages of lymphocyte development to promote normal immune cell maturation.
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Concluding Remarks
All lymphocytes generate DSBs as they
assemble functional antigen receptor genes
at different developmental stages. The
specific antigen receptor genes that are
rearranged and the timing of the DSBs
generation are regulated by surface receptor signals, such as those from the IL-7r and
the pre-BCR in developing B cells. These
external cellular cues trigger pathways that
control (1) accessibility of antigen receptor genes to transcriptional machinery, (2)
RAG recombinase expression and (3) cell
proliferation and survival. In large, pre-B
cells, IL-7r and pre-BCR signals cooperate
to promote survival, proliferation and clonal
expansion while suppressing RAG expression and IgL chain gene accessibility (Fig.
1). To continue maturation and transition
to the small pre-B cell stage, IL-7r signaling
must be attenuated, which occurs, at least
in part, through migration away from IL-7producing stromal cells. Loss of IL-7 signals
results in expression of RAG, IgL germline
transcription and modification of pre-BCR
signaling. Once generated, the RAG DSBs
themselves trigger a DNA damage response
that activates a unique lymphocyte-specific
program, which intersects with IL-7r and
antigen receptor signals to direct lymphocyte differentiation. In this regard, RAG
DSBs and the pre-BCR regulate pathways
to suppress the proliferative response to IL-7
and likely promote pre-B cell residence in
bone marrow niches devoid of IL-7 (Fig. 1).
Together, these mechanisms maintain G1
arrest in cells undergoing IgL recombination. Simultaneously, RAG DSBs activate
survival mechanisms to replace loss IL-7driven survival signals, permitting time for
repair of the broken DNA ends and expression of a functional IgL chain gene. The
integration of these DNA damage responses
with extrinsic development cues creates a
coordinated signaling network to manage DNA breaks, enforce normal lymphocyte development and suppress malignant
transformation.
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expression of Pim2, a member of a family of pro-survival kinases that includes
Pim1 and Akt.31,42,63 Upregulation of
Pim2 provides a cytokine-independent
survival signal through maintenance of
the phosphorylation and inactivation of
BAD, which promotes increased levels of
Bcl2.31,36 This early survival signal counters p53-associated cell death mechanisms, allowing time for proper repair of
RAG DSBs and assembly of a functional
IgL chain gene.
Pre-B cells frequently must undergo
several successive IgL chain gene rearrangements, each of which can take several hours to complete. Thus, pre-B cells
need to survive for an extended period
of time as they attempt to assemble and
express a functional IgL chain gene.64
Indeed, Pim2-deficient mice have fewer
IgLλ-expressing B cells, consistent with
reduced pre-B cell survival and time
to complete IgL chain gene rearrangement.31,65 The pro-survival functions of
Pim2 replace lost IL-7 survival signals to
counter cell death mechanisms and provide optimal opportunity for completion
of IgL chain gene assembly. Importantly,
if DSBs cannot be repaired, cell death
pathways overcome the early survival signals to eliminate cells at risk of aberrant
DSB repair, such as translocations. Thus,
expression of Pim2 by RAG DSBs results
in a temporal ordering of early survival
followed by late cell death mechanisms,
which promotes normal lymphocyte
development while suppressing malignant
transformation.
In striking contrast to the pro-proliferative properties of Pim1 and Akt
downstream of IL-7, expression of Pim2
by RAG DSBs inhibits IL-7-driven proliferation.31,66,67 The mechanisms underlying the anti-proliferative properties of
Pim2 are unclear. Notably, though, Pim2
is not sufficient to block proliferation
but functions in conjunction with other
DSB-dependent checkpoint activators to
maintain cell cycle arrest.31 This unique
function of Pim2 in cells undergoing
V(D)J recombination may be important
to help enforce the G1 to S checkpoint in
the presence of low levels of IL-7. As such,
the anti-proliferative function of Pim2
downstream of RAG DSBs may integrate
with pre-BCR signals to inhibit IL-7r

1. Tonegawa S. Somatic generation of antibody diversity. Nature 1983; 302:575-81; PMID:6300689;
http://dx.doi.org/10.1038/302575a0.
2. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz
DG. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu Rev
Immunol 2000; 18:495-527; PMID:10837067;
h t t p : / / d x . d o i . o r g / 10 .114 6 / a n n u r e v. i m m u nol.18.1.495.
3. Gellert MV. V(D)J recombination: RAG proteins,
repair factors, and regulation. Annu Rev Biochem
2002; 71:101-32; PMID:12045092; http://dx.doi.
org/10.1146/annurev.biochem.71.090501.150203.
4. Oettinger MA. V(D)J recombination: on the cutting edge. Curr Opin Cell Biol 1999; 11:325-9;
PMID:10395566; http://dx.doi.org/10.1016/S09550674(99)80044-1.
5. Helmink BA, Sleckman BP. The response to and
repair of R AG-mediated DNA double-strand
breaks. Annu Rev Immunol 2012; 30:175-202;
PMID:22224778;
http://dx.doi.org/10.1146/
annurev-immunol-030409-101320.
6. Lieber MR. The mechanism of double-strand DNA
break repair by the nonhomologous DNA endjoining pathway. Annu Rev Biochem 2010; 79:181211; PMID:20192759; http://dx.doi.org/10.1146/
annurev.biochem.052308.093131.
7. Rooney S, Chaudhuri J, Alt FW. The role of the
non-homologous end-joining pathway in lymphocyte development. Immunol Rev 2004; 200:115-31;
PMID:15242400; http://dx.doi.org/10.1111/j.01052896.2004.00165.x.
8. Herzog S, Reth M, Jumaa H. Regulation of B-cell
proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9:195205; PMID:19240758; http://dx.doi.org/10.1038/
nri2491.
9. Nemazee D, Kouskoff V, Hertz M, Lang J, Melamed
D, Pape K, et al. B-cell-receptor-dependent positive and negative selection in immature B cells.
Curr Top Microbiol Immunol 2000; 245:57-71;
PMID:10533318; http://dx.doi.org/10.1007/978-3642-59641-4_3.
10. Corfe SA, Paige CJ. The many roles of IL-7 in B
cell development; mediator of survival, proliferation
and differentiation. Semin Immunol 2012; 24:198208; PMID:22421572; http://dx.doi.org/10.1016/j.
smim.2012.02.001.
11. Erlandsson L, Licence S, Gaspal F, Lane P, Corcoran
AE, Mårtensson IL. Both the pre-BCR and the
IL-7Ralpha are essential for expansion at the pre-BII
cell stage in vivo. Eur J Immunol 2005; 35:196976; PMID:15909309; http://dx.doi.org/10.1002/
eji.200425821.
12. Desiderio S, Lin WC, Li Z. The cell cycle and V(D)
J recombination. Curr Top Microbiol Immunol
1996; 217:45-59; PMID:8787617; http://dx.doi.
org/10.1007/978-3-642-50140-1_4.
13. Durocher D, Jackson SP. DNA-PK, ATM and ATR as
sensors of DNA damage: variations on a theme? Curr
Opin Cell Biol 2001; 13:225-31; PMID:11248557;
http://dx.doi.org/10.1016/S0955-0674(00)00201-5.
14. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer
2003; 3:155-68; PMID:12612651; http://dx.doi.
org/10.1038/nrc1011.
15. Smith GC, Jackson SP. The DNA-dependent
protein kinase. Genes Dev 1999; 13:916-34;
PMID :10215620 ;
http://dx.doi.org/10.1101/
gad.13.8.916.
16. Hill R, Lee PW. The DNA-dependent protein kinase
(DNA-PK): More than just a case of making ends
meet? Cell Cycle 2010; 9:3460-9; PMID:20855954;
http://dx.doi.org/10.4161/cc.9.17.13043.

www.landesbioscience.com

17. Gapud EJ, Sleckman BP. Unique and redundant
functions of ATM and DNA-PKcs during V(D)
J recombination. Cell Cycle 2011; 10:1928-35;
PMID :21673501;
http://dx.doi.org/10.4161/
cc.10.12.16011.
18. Gapud EJ, Dorsett Y, Yin B, Callen E, Bredemeyer A,
Mahowald GK, et al. Ataxia telangiectasia mutated
(Atm) and DNA-PKcs kinases have overlapping
activities during chromosomal signal joint formation. Proc Natl Acad Sci USA 2011; 108:20227; PMID:21245316; http://dx.doi.org/10.1073/
pnas.1013295108.
19. Barlow C, Hirotsune S, Paylor R, Liyanage M,
Eckhaus M, Collins F, et al. Atm-deficient mice: a
paradigm of ataxia telangiectasia. Cell 1996; 86:15971; PMID:8689683; http://dx.doi.org/10.1016/
S0092-8674(00)80086-0.
20. Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou
F, Campos-Torres J, et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl
Acad Sci USA 1996; 93:13084-9; PMID:8917548;
http://dx.doi.org/10.1073/pnas.93.23.13084.
21. Lavin MF, Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 1997; 15:177-202;
PMID:9143686; http://dx.doi.org/10.1146/annurev.
immunol.15.1.177.
22. van der Burg M, Ijspeert H, Verkaik NS, Turul T,
Wiegant WW, Morotomi-Yano K, et al. A DNAPKcs mutation in a radiosensitive T-B- SCID
patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest 2009; 119:91-8;
PMID:19075392.
23. Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn
MS, Baltimore D. Targeted disruption of ATM leads
to growth retardation, chromosomal fragmentation
during meiosis, immune defects, and thymic lymphoma. Genes Dev 1996; 10:2411-22; PMID:8843194;
http://dx.doi.org/10.1101/gad.10.19.2411.
24. Bredemeyer AL, Sharma GG, Huang CY, Helmink
BA, Walker LM, Khor KC, et al. ATM stabilizes DNA double-strand-break complexes during
V(D)J recombination. Nature 2006; 442:46670; PMID:16799570; http://dx.doi.org/10.1038/
nature04866.
25. Goodarzi AA, Yu Y, Riballo E, Douglas P, Walker
SA, Ye R, et al. DNA-PK autophosphorylation
facilitates Artemis endonuclease activity. EMBO J
2006; 25:3880-9; PMID:16874298; http://dx.doi.
org/10.1038/sj.emboj.7601255.
26. Ma Y, Pannicke U, Schwarz K, Lieber MR. Hairpin
opening and overhang processing by an Artemis/
DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell
2002; 108:781-94; PMID:11955432; http://dx.doi.
org/10.1016/S0092-8674(02)00671-2.
27. Savic V, Yin B, Maas NL, Bredemeyer AL, Carpenter
AC, Helmink BA, et al. Formation of dynamic
gamma-H2AX domains along broken DNA strands
is distinctly regulated by ATM and MDC1 and
dependent upon H2AX densities in chromatin. Mol
Cell 2009; 34:298-310; PMID:19450528; http://
dx.doi.org/10.1016/j.molcel.2009.04.012.
28. Fernandez-Capetillo O, Lee A, Nussenzweig M,
Nussenzweig A. H2AX: the histone guardian of
the genome. DNA Repair (Amst) 2004; 3:95967; PMID:15279782; http://dx.doi.org/10.1016/j.
dnarep.2004.03.024.
29. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner
WM. DNA double-stranded breaks induce histone
H2AX phosphorylation on serine 139. J Biol Chem
1998; 273:5858-68; PMID:9488723; http://dx.doi.
org/10.1074/jbc.273.10.5858.
30. Helmink BA, Tubbs AT, Dorsett Y, Bednarski JJ,
Walker LM, Feng Z, et al. H2AX prevents CtIPmediated DNA end resection and aberrant repair
in G1-phase lymphocytes. Nature 2011; 469:2459; PMID:21160476; http://dx.doi.org/10.1038/
nature09585.

Cell Cycle

31. Bednarski JJ, Nickless A, Bhattacharya D, Amin
RH, Schlissel MS, Sleckman BP. R AG-induced
DNA double-strand breaks signal through Pim2 to
promote pre-B cell survival and limit proliferation. J
Exp Med 2012; 209:11-7; PMID:22201128; http://
dx.doi.org/10.1084/jem.20112078.
32. Guidos CJ, Williams CJ, Grandal I, Knowles G,
Huang MT, Danska JS. V(D)J recombination
activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev
1996; 10:2038-54; PMID:8769647; http://dx.doi.
org/10.1101/gad.10.16.2038.
33. Vousden KH, Prives C. Blinded by the Light: The
Growing Complexity of p53. Cell 2009; 137:41331; PMID:19410540; http://dx.doi.org/10.1016/j.
cell.2009.04.037.
34. Perkins EJ, Nair A, Cowley DO, Van Dyke T, Chang
Y, Ramsden DA. Sensing of intermediates in V(D)J
recombination by ATM. Genes Dev 2002; 16:15964; PMID:11799059; http://dx.doi.org/10.1101/
gad.956902.
35. Zhou BB, Elledge SJ. The DNA damage response:
putting checkpoints in perspective. Nature 2000;
408:433-9; PMID:11100718; http://dx.doi.
org/10.1038/35044005.
36. Youle RJ, Strasser A. The BCL-2 protein family:
opposing activities that mediate cell death. Nat Rev
Mol Cell Biol 2008; 9:47-59; PMID:18097445;
http://dx.doi.org/10.1038/nrm2308.
37. Rowh MA, DeMicco A, Horowitz JE, Yin B, YangIott KS, Fusello AM, et al. Tp53 deletion in B
lineage cells predisposes mice to lymphomas with
oncogenic translocations. Oncogene 2011; 30:475764; PMID:21625223; http://dx.doi.org/10.1038/
onc.2011.191.
38. Difilippantonio MJ, Petersen S, Chen HT, Johnson
R, Jasin M, Kanaar R, et al. Evidence for replicative
repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp
Med 2002; 196:469-80; PMID:12186839; http://
dx.doi.org/10.1084/jem.20020851.
39. Gladdy RA, Taylor MD, Williams CJ, Grandal I,
Karaskova J, Squire JA, et al. The RAG-1/2 endonuclease causes genomic instability and controls CNS
complications of lymphoblastic leukemia in p53/
Prkdc-deficient mice. Cancer Cell 2003; 3:37-50;
PMID:12559174; http://dx.doi.org/10.1016/S15356108(02)00236-2.
40. Zhu C, Mills KD, Ferguson DO, Lee C, Manis J,
Fleming J, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification
subsequent to translocations. Cell 2002; 109:811-21;
PMID:12110179; http://dx.doi.org/10.1016/S00928674(02)00770-5.
41. Rooney S, Sekiguchi J, Whitlow S, Eckersdorff M,
Manis JP, Lee C, et al. Artemis and p53 cooperate to
suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 2004; 101:24105; PMID:14983023; http://dx.doi.org/10.1073/
pnas.0308757101.
42. Bredemeyer AL, Helmink BA, Innes CL, Calderon
B, McGinnis LM, Mahowald GK, et al. DNA
double-strand breaks activate a multi-functional
genetic program in developing lymphocytes. Nature
2008; 456:819-23; PMID:18849970; http://dx.doi.
org/10.1038/nature07392.
43. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell
FJ, Maraskovsky E, Gliniak BC, et al. Early lymphocyte expansion is severely impaired in interleukin 7
receptor-deficient mice. J Exp Med 1994; 180:195560; PMID:7964471; http://dx.doi.org/10.1084/
jem.180.5.1955.
44. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil
T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a
nonredundant cytokine. J Exp Med 1995; 181:151926; PMID:7699333; http://dx.doi.org/10.1084/
jem.181.4.1519.

5

©2012 Landes Bioscience. Do not distribute.

References

6

57. Thompson EC, Cobb BS, Sabbattini P, Meixlsperger
S, Parelho V, Liberg D, et al. Ikaros DNA-binding
proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity
2007; 26:335-44; PMID:17363301; http://dx.doi.
org/10.1016/j.immuni.2007.02.010.
58. Johnson K, Hashimshony T, Sawai CM, Pongubala
JM, Skok JA, Aifantis I, et al. Regulation of immunoglobulin light-chain recombination by the
transcription factor IRF-4 and the attenuation of
interleukin-7 signaling. Immunity 2008; 28:33545; PMID:18280186; http://dx.doi.org/10.1016/j.
immuni.2007.12.019.
59. Marshall AJ, Fleming HE, Wu GE, Paige CJ.
Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B
cell receptor expression. J Immunol 1998; 161:603845; PMID:9834086.
60. Schebesta M, Pfeffer PL, Busslinger M. Control of
pre-BCR signaling by Pax5-dependent activation
of the BLNK gene. Immunity 2002; 17:473-85;
PMID:12387741; http://dx.doi.org/10.1016/S10747613(02)00418-1.
61. Rolink A, Kudo A, Karasuyama H, Kikuchi Y,
Melchers F. Long-term proliferating early pre B cell
lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and
in vivo. EMBO J 1991; 10:327-36; PMID:1991449.
62. Rolink A, Streb M, Melchers F. The kappa/lambda
ratio in surface immunoglobulin molecules on B
lymphocytes differentiating from DHJH-rearranged
murine pre-B cell clones in vitro. Eur J Immunol
1991; 21:2895-8; PMID:1936127; http://dx.doi.
org/10.1002/eji.1830211137.
63. Amaravadi R, Thompson CB. The survival kinases
Akt and Pim as potential pharmacological targets.
J Clin Invest 2005; 115:2618-24; PMID:16200194;
http://dx.doi.org/10.1172/JCI26273.
64. Casellas R, Shih TA, Kleinewietfeld M, Rakonjac
J, Nemazee D, Rajewsky K, et al. Contribution of
receptor editing to the antibody repertoire. Science
2001; 291:1541-4; PMID:11222858; http://dx.doi.
org/10.1126/science.1056600.
65. Derudder E, Cadera EJ, Vahl JC, Wang J, Fox
CJ, Zha S, et al. Development of immunoglobulin lambda-chain-positive B cells, but not editing of immunoglobulin kappa-chain, depends on
NF-kappaB signals. Nat Immunol 2009; 10:64754; PMID:19412180; http://dx.doi.org/10.1038/
ni.1732.
66. Domen J, van der Lugt NM, Acton D, Laird PW,
Linders K, Berns A. Pim-1 levels determine the size
of early B lymphoid compartments in bone marrow.
J Exp Med 1993; 178:1665-73; PMID:8228813;
http://dx.doi.org/10.1084/jem.178.5.1665.
67. Mikkers H, Nawijn M, Allen J, Brouwers C,
Verhoeven E, Jonkers J, et al. Mice deficient for all
PIM kinases display reduced body size and impaired
responses to hematopoietic growth factors. Mol Cell
Biol 2004; 24:6104-15; PMID:15199164; http://
dx.doi.org/10.1128/MCB.24.13.6104-6115.2004.

Cell Cycle

68. Feng C, Woodside KJ, Vance BA, El-Khoury D,
Canelles M, Lee J, et al. A potential role for CD69 in
thymocyte emigration. Int Immunol 2002; 14:53544; PMID:12039905; http://dx.doi.org/10.1093/
intimm/dxf020.
69. Pearce G, Angeli V, Randolph GJ, Junt T, von
Andrian U, Schnittler HJ, et al. Signaling protein
SWAP-70 is required for efficient B cell homing to
lymphoid organs. Nat Immunol 2006; 7:827-34;
PMID:16845395; http://dx.doi.org/10.1038/ni1365.
70. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004;
22:129-56 ; PMID:15032576 ; http://dx.doi.
org/10.1146/annurev.immunol.21.090501.080131.
71. Shiow LR, Rosen DB, Brdicková N, Xu Y, An J,
Lanier LL, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress
from lymphoid organs. Nature 2006; 440:5404; PMID:16525420; http://dx.doi.org/10.1038/
nature04606.
72. Schwab SR, Cyster JG. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol
2007; 8:1295-301; PMID:18026082; http://dx.doi.
org/10.1038/ni1545.
73. Galkina E, Florey O, Zarbock A, Smith BR, Preece
G, Lawrence MB, et al. T lymphocyte rolling and
recruitment into peripheral lymph nodes is regulated
by a saturable density of L-selectin (CD62L). Eur
J Immunol 2007; 37:1243-53; PMID:17429841;
http://dx.doi.org/10.1002/eji.200636481.
74. Subramanian H, Grailer JJ, Ohlrich KC,
Rymaszewski AL, Loppnow JJ, Kodera M, et al.
Signaling through L-selectin mediates enhanced
chemotaxis of lymphocyte subsets to secondary lymphoid tissue chemokine. J Immunol 2012; 188:322336; PMID:22387549; http://dx.doi.org/10.4049/
jimmunol.1101032.
75. Allende ML, Tuymetova G, Lee BG, Bonifacino E,
Wu YP, Proia RL. S1P1 receptor directs the release of
immature B cells from bone marrow into blood. J Exp
Med 2010; 207:1113-24; PMID:20404103; http://
dx.doi.org/10.1084/jem.20092210.
76. Pereira JP, Xu Y, Cyster JG. A role for S1P and S1P1
in immature-B cell egress from mouse bone marrow.
PLoS One 2010; 5:e9277; PMID:20174580; http://
dx.doi.org/10.1371/journal.pone.0009277.
77. Sherman MH, Kuraishy AI, Deshpande C, Hong
JS, Cacalano NA, Gatti RA, et al. AID-induced
genotoxic stress promotes B cell differentiation in the
germinal center via ATM and LKB1 signaling. Mol
Cell 2010; 39:873-85; PMID:20864035; http://
dx.doi.org/10.1016/j.molcel.2010.08.019.
78. Walsh NC, Teitell M. B-cell differentiation stimulated by physiologic DNA double strand breaks.
Cell Cycle 2011; 10:176-7; PMID:21212732; http://
dx.doi.org/10.4161/cc.10.2.14474.

Volume 11 Issue 22

©2012 Landes Bioscience. Do not distribute.

45. Goetz CA, Harmon IR, O’Neil JJ, Burchill MA,
Farrar MA. STAT5 activation underlies IL7 receptordependent B cell development. J Immunol 2004;
172:4770-8; PMID:15067053.
46. Malin S, McManus S, Cobaleda C, Novatchkova
M, Delogu A, Bouillet P, et al. Role of STAT5 in
controlling cell survival and immunoglobulin gene
recombination during pro-B cell development. Nat
Immunol 2010; 11:171-9; PMID:19946273; http://
dx.doi.org/10.1038/ni.1827.
47. Bertolino E, Reddy K, Medina KL, Parganas E, Ihle
J, Singh H. Regulation of interleukin 7-dependent
immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. Nat
Immunol 2005; 6:836-43; PMID:16025120; http://
dx.doi.org/10.1038/ni1226.
48. Mandal M, Powers SE, Ochiai K, Georgopoulos K,
Kee BL, Singh H, et al. Ras orchestrates exit from the
cell cycle and light-chain recombination during early
B cell development. Nat Immunol 2009; 10:11107; PMID:19734904; http://dx.doi.org/10.1038/
ni.1785.
49. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum
SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem
2004; 279:29160-6; PMID:15123689; http://dx.doi.
org/10.1074/jbc.M401656200.
50. Amin RH, Schlissel MS. Foxo1 directly regulates the
transcription of recombination-activating genes during B cell development. Nat Immunol 2008; 9:61322; PMID:18469817; http://dx.doi.org/10.1038/
ni.1612.
51. Herzog S, Hug E, Meixlsperger S, Paik JH, DePinho
RA, Reth M, et al. SLP-65 regulates immunoglobulin
light chain gene recombination through the PI(3)
K-PKB-Foxo pathway. Nat Immunol 2008; 9:62331; PMID:18488031; http://dx.doi.org/10.1038/
ni.1616.
52. Lazorchak AS, Liu D, Facchinetti V, Di Lorenzo A,
Sessa WC, Schatz DG, et al. Sin1-mTORC2 suppresses rag and il7r gene expression through Akt2 in B
cells. Mol Cell 2010; 39:433-43; PMID:20705244;
http://dx.doi.org/10.1016/j.molcel.2010.07.031.
53. Ochiai K, Maienschein-Cline M, Mandal M, Triggs
JR, Bertolino E, Sciammas R, et al. A self-reinforcing
regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation. Nat
Immunol 2012; 13:300-7; PMID:22267219; http://
dx.doi.org/10.1038/ni.2210.
54. Bankovich AJ, Raunser S, Juo ZS, Walz T, Davis MM,
Garcia KC. Structural insight into pre-B cell receptor
function. Science 2007; 316:291-4; PMID:17431183;
http://dx.doi.org/10.1126/science.1139412.
55. Bergman Y. Allelic exclusion in B and T lymphopoiesis. Semin Immunol 1999; 11:319-28;
PMID:10497086 ;
http://dx.doi.org/10.1006/
smim.1999.0188.
56. Brady BL, Steinel NC, Bassing CH. Antigen receptor allelic exclusion: an update and reappraisal.
J Immunol 2010; 185:3801-8; PMID:20858891;
http://dx.doi.org/10.4049/jimmunol.1001158.

